School of Medicine
Showing 12,151-12,200 of 13,024 Results
-
Eva Weinlander
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsWomen's Health
Mind Body Medicine
Chronic Disease Management -
Ashira Weinreich
Masters Student in Community Health and Prevention Research, admitted Autumn 2025
BioAshira is a National Science Foundation Graduate Research Fellow (NSF-GRFP), completing her MS in Community Health and Prevention Research at Stanford University (2025 - June 2026), and a Community Engaged Scholar at Stanford's Haas Center for Public Service. Her research examines how diverse bio-cultural systems inform community health in times of sociocultural and ecological change. By linking cyclical patterns in health practices with seasonality, nutrient intake, and medicinal plant use, Ashira explores how village communities adapt to climatic and environmental variability. As a Fulbright Research Fellow in Nepal (2024-2025), Ashira interviewed community members, organized and facilitated workshops in 12 villages ranging in elevation from 6,500ft to 13,000ft, engaging over 200 villagers. She believes that anticipatory capacity is important in developing resilience in Nepal’s high-altitude Himalayan regions. Ashira is committed to a collaborative, community-centered approach to research, emphasizing the importance of reciprocity and giving back to the community.
-
Dana Weintraub
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsResearch interests include: 1) Childhood obesity, community-based interventions to increase physical activity 2) Impact of medical-legal collaboration on child and family health.
-
Thomas G Weiser, MD, MPH
Clinical Professor, Surgery - General Surgery
BioDr. Thomas Weiser is a general, emergency, and trauma surgeon, and surgical intensivist. He treats and cares for injured patients and those with acute surgical emergencies as well as manages critically ill surgical patients in the Intensive Care Unit.
His research has focused on evaluating the role surgical care plays in the delivery of health services in resource poor settings, in particular low and middle income countries. He is interested in barriers to access and provision of surgical care, the quality of surgical services, and outcomes research as well as the science of implementation, how improvements can be made, and how to strengthen compliance with best practices and change behaviors for the better. He also has an interest in domestic policy as it relates to trauma outcomes, trauma systems, insurance coverage and costs of care, and firearm violence.
Dr. Weiser's efforts have led to improvements in the safety and reliability of surgical service, the quality of surgical care delivered globally, and improvements team dynamics, function, and communication. He works closely with Lifebox, a nonprofit focused on improving surgical and anesthetic safety worldwide, where he was previously the Consulting Medical Officer. Lifebox delivers programs throughout the world in combination with local partners and includes the procurement and distribution of low cost devices to improve the safety of care (including pulse oximeters for the routine monitoring of patients undergoing anesthesia and surgical headlights to safeguard care during power outage) and Clean Cut, a surgical infection prevention and control program that has reduced complications by up to 50%. This work safeguards millions of surgical patients every year.
From 2006-2009, he was part of the World Health Organization’s Safe Surgery Saves Lives program where he quantified the global volume of surgery and created, implemented, evaluated, and promoted the WHO Surgical Safety Checklist. He was part of the Lancet Commission on Global Surgery, the World Bank Disease Control Priorities Program, and a Gates Grand Challenge awardee.
From 2022-2026 he was the Program Director of Surgery: Assess/Validate/Expand (SAVE) at Wellcome Leap. His current research efforts aim to accelerate computer vision models for quantifying surgical performance and identifying mechanisms to predict patient recovery trajectories following surgery. -
Eric A Weiss, MD, FACEP
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy focus of research is wilderness medicine, including hypothermia, heat illness, altitude illness, improvised medical care in austere environments and wound care. I also have a strong interest in Disaster Medicine, Travel Medicine and International Health, and Pandemics.
-
Eric L. Weiss, MD, DTM&H
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsIgnorance of Hepatitis A Among Travelers (writing up data).Travelers Neglecting to Seek Pre Travel Medicine Advice (writing up data).Fluoroquinolones in the Treatment of Complicated Urinary Tract Infections (new ED study)
-
Irving Weissman
Virginia & D.K. Ludwig Professor of Clinical Investigation in Cancer Research, Professor of Pathology, and of Developmental Biology
Current Research and Scholarly InterestsStem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis; order of events from hematopoietic stem cells [HSC] to AML leukemia stem cells and blood diseases, and parallels in other tissues; discovery of tumor and pathogenic cell 'don't eat me' and 'eat me' signals, and translation into therapeutics.
-
Chad S. Weldy, M.D., Ph.D.
Instructor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAs a physician-scientist I work to understand the genetic basis of cardiovascular disease and the transcriptional and epigenomic mechanisms of atherosclerosis. My work is focused across four main areas of cardiovascular genetics and mechanisms of coronary artery disease and smooth muscle biology:
1.Vascular smooth muscle specific ADAR1 mediated RNA editing of double stranded RNA and activation of the double stranded RNA receptor MDA5 in coronary artery disease and vascular calcification
2.Defining on single cell resolution the cellular and epigenomic features of human vascular disease across vascular beds of differing embryonic origin
3.CRISPRi screening with targeted perturb seq (TAPseq) to identify novel CAD genes in human coronary artery smooth muscle cells
4.Investigation of the epigenetic and molecular basis of coronary artery disease and smooth muscle cell transition in mice with conditional smooth muscle genetic deletion of CAD genes Pdgfd and Sox9
My work is focused on discovery of causal mechanisms of disease through leveraging human genetics with sophisticated molecular biology, single cell sequencing technologies, and mouse models of disease. This work attempts to apply multiple scientific research arms to ultimately lead to novel understandings of vascular disease and discover important new therapeutic approaches for drug discovery.
First Author Manuscripts for this work:
•Weldy, C. S., et al. (2025). Smooth muscle cell expression of RNA editing enzyme ADAR1 controls activation of RNA sensor MDA5 in atherosclerosis. (2025). Nature Cardiovascular Research. 1-17, PMID: 40958051, doi: 10.1038/s44161-025-00710-5
•*Selected as finalist for Louis N. and Arnold M. Katz Basic Science Research Prize from the American Heart Association, finalist competition November 16, 2024, Chicago
•Work was highlighted in the Stanford Department of Medicine News
https://medicine.stanford.edu/news/current-news/standard-news/RNA-editing.html
•Weldy, C.S., et al. (2025). Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci. Molecular Systems Biology. 1-25, PMID: 40931195, doi:10.1038/s44320-025-00140-2.
•*Selected for the cover of November 2025 edition of Molecular Systems Biology
Grant funding received for this work:
Mentored Clinical Scientist Research Career Development Award (K08)(NIH/NHLBI, 1 K08 HL167699-01), August, 2023 – July 2028. PI: Weldy, Chad
•Title of proposal: “ADAR Mediated RNA editing is a causal mechanism in coronary artery disease”.
•Activated 08/01/2023
•$850,000 over 5 years
Career Development Award, American Heart Association (AHA CDA)(23CDA1042900), July, 2023 – June, 2026. PI: Weldy, Chad
•Title of proposal: “Linking RNA editing to coronary artery calcification and disease”
•Activated 07/01/2023
•$231,000 over three years
NIH Loan Repayment Program (LRP) Award (NIH/NHLBI) Renewal Award, July, 2023. PI: Weldy, Chad
•Title of proposal: “RNA editing is a causal mechanism of coronary artery disease”
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (NIH/NHLBI, 1 F32 HL160067-01), July, 2021 – June 2023 (Completed). PI: Weldy, Chad
• Titled, “A transcriptional network which governs smooth muscle transition is mediated by causal coronary artery disease gene PDGFD”
•*Received perfect score with impact score 10, 1st percentile
NIH Loan Repayment Program (LRP) Award (NIH/NHLBI), July, 2021. PI: Weldy, Chad
•Title of proposal: "Single cell transcriptomic and epigenomic features of human atherosclerosis".
•This will award up to $100,000 towards student loans over the next 24 months with opportunity for renewal after 24 months. -
Andy Wen
Clinical Professor, Pediatrics - Critical Care
BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.
After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).
While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.
At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital. -
Gerald Wen
IT Manager, Anesthesiology, Perioperative and Pain Medicine
Current Role at StanfordIT Manager
Tuesday/Thursday @ Redwood City Campus, Discovery Hall -
Paul Wender
Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis
-
Kirsti Weng Elder MD/MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Weng is the Section Chief of General Primary Care. She has over 25 years of experience caring for patients in primary care, urgent care and in the hospital. She is also a teacher of students and residents. As a leader in primary care re-design, she is passionate about practicing patient-centered medicine. She is a an advocate of Mindfulness Self-compassion to develop equanimity. She practices with an emphasis on musculoskeletal care as she feels fitness is the foundation of wellness. She is a leader in organizational change and physician management. She supports community health and care for the underserved. Outside of work she enjoys biking, reading and spending time with her 8 children.
-
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
On Partial Leave from 04/06/2026 To 06/12/2026Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.
-
Yingjie Weng
Assistant Director, Learning Health Systems Program, Med/Quantitative Sciences Unit
Current Role at StanfordResponsibilities - Assistant Director, Learning Health Systems Program (LHS)
Program Development & Resource Management
•Establish and update LHS program resources, including standard operating procedures, statistical analysis plan templates, and training materials.
Training & Mentorship
•Host onboarding training programs for new QSU hires and conduct regular training sessions within QSU.
•Establish and mentor a core team of statisticians and data scientists dedicated to the LHS program.
Project Oversight & Strategy
•Guide project assignments related to quality improvement, pragmatic trials, and real-world evidence studies utilizing electronic health records (EHRs).
Collaboration & Relationship Management
•Maintain strong partnerships with clinical advocates of LHS projects across collaborating departments.
•Host onboarding sessions with department leaders to communicate the program’s mission and objectives.
•Establish collaborations with various data teams across campus
Education & Outreach
•Organize educational sessions and lectures for clinical investigators across partnering departments.
•Serve as the primary point of contact for QSU regarding the LHS program.
--------------------------------------------------------------------------------------------------------------------------------
Responsibilities - Senior Biostatistician
Scientific Collaboration & Research Support
•Partner with research investigators on a wide range of scientific studies across the School of Medicine and Stanford Healthcare system.
Study Design & Statistical Planning
•Lead the development of study protocols and statistical analysis plans.
Data Management & Analysis
•Perform data management, visualization, and statistical analysis using advanced methodologies and tools.
Results Interpretation & Reporting
•Interpret statistical results and translate findings into clear, domain-specific language for publications and reports.
Grant & Manuscript Development
•Lead statistical methodology and results sections for grant applications, manuscript submissions, and public health reports.
Methodological Research
•Conduct research on statistical methodologies to enhance study designs and analytical approaches.
Mentorship & Teaching
•Mentor junior statisticians and serve as a KL2 research methodology mentor.
•Deliver lectures, including presentations for Hospital Medicine Grand Rounds. -
Gerlinde Wernig
Associate Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Philipp Wesp
Postdoctoral Scholar, Radiology
BioI am a postdoctoral researcher investigating interpretable machine learning (ML) and large language model (LLM) applications in clinical radiology. My current research focuses on two complementary areas: understanding what human-interpretable concepts self-supervised vision foundation models learn through mechanistic interpretability techniques like sparse autoencoders, and developing LLM-based systems, including agentic workflows and retrieval augmented generation (RAG) architectures, that leverage unstructured hospital data to improve radiological workflows. I earned my PhD from LMU Munich, where I focused on clinically motivated machine learning applications in medical imaging in the Department of Radiology.
My work is partially funded by a Walter Benjamin Fellowship from the DFG (German Research Foundation). -
Dee W. West
Professor of Health Research and Policy, Emeritus
Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
- Cancer surveillance (Cancer registration, cancer patterns)
- Cancer outcomes (Survival, quality of life, quality of care) -
Robert West
Sabine Kohler, MD, Professor of Pathology
Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.
-
Lynn Marie Westphal, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsInfertility, fertility preservation, oocyte cryopreservation
-
Cornelia Weyand
Professor of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsAutoimmunity
Chronic inflammatory disease
Metabolic control of immune function -
Christopher Weyant
Temp - Non-Exempt, Health Policy
BioI am a Postdoctoral Scholar working in the field of health analytics. I previously completed a PhD in Management Science and Engineering, MS in Bioengineering, and BS in Chemical Engineering at Stanford. In my postdoc, I am developing and applying data-driven methods and models to solve problems in the healthcare sector.
-
Jessica Whalen, MS
Program Director, Peds/Child Health Research Program
Current Role at StanfordProgram Director (PEDSnet) & Data Manager (Stanford Assessments of Bone Across the ages (SAMBA Center))
-
Ryan Whaley
Technical Lead, Biomedical Data Science
Current Role at StanfordRyan is a software developer in the Department of Genetics and a co-technical lead of the PharmGKB. He is a Java developer with a background in database administration and project management and has been with the PharmGKB since 2007.
